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AbStRACt
Oral candidiasis represents a serious problem for children with cancer. The mortality rate of this infection has increased 
due to fungal septicemia, associated with a primary buccal infection. Objective: Identify the Candida spp. in buccal le-
sions of patients with cancer, establish the predominant species and correlate them to age and sex of the patient, clinical 
presentation, type of neoplasic disease and cytostatic therapy received. Study design: 62 patients, between 0-16 years, 
were investigated in a cross sectional study. Sample inclusion criteria: Patients with malignant neoplasic disease that 
were receiving cytostatic treatment and had suspicious lesions of oral candidiasis. Patients with antifungal therapy, ac-
tive caries, calculus or intraoral appliances were excluded. A clinical evaluation was carried out. The lesion sample was 
taken and studied by direct exam and culture in CHROMagar-Candida and Sabouraud-Dextrose Agar with chloram-
phenicol. The identification of the isolated yeast was done by the filamentation test, carbohydrate fermentation and 
assimilation. Results: Most of the cases (69.35%) were positive to oral candidiasis, C. albicans was the most frequent 
species found, followed by C. parapsilosis (14.89%), C. tropicalis (12.77%), C. krusei (4.26%), C. glabrata (2.13%) and 
C. lusitaniae (2.13 %). In some cases more than one specie were isolated (9.30%). The most frequent location of the le-
sion was in the tongue (72.70%). The pseudomembranous candidiasis was the most frequent clinical presentation found 
(78.71%). There were not significant statistically differences with regard to sex and age of the patient, type of neoplasic 
disease and cytostatic agent received. Conclusion: The results suggest that oral candidiasis is a frequent complication 
in the pediatric oncological population, being C. albicans the main etiological agent, however, there is an important 
participation of other Candida species.
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IntROduCtIOn         
Oral candidiasis, a frequent and important nosologic entity 
of the buccal cavity; is caused by the pathogenic action of 
Candida species (1). There are diverse local factors that make 
the buccal tissues susceptible to Candida infection, such as 
acid saliva, xerostomia, night use of prosthetic dentures, 
tobacco, carbohydrate rich-diets and patients that receive 
radio- and chemotherapies in maxillofacial structures (2).  
The colonization for species of Candida genus in patients 
with cancer and their later dissemination, associated with 
long term episodes of  neutrophenia, use wide spectrum 
antibiotics, treatment with corticosteroids and cytostatic 
substances, invasive surgical procedures (central and bladder 
catheters), xerostomia and prolonged hospitalization time 
(3). The mortality rate due to fungal septicemia, associated 
with a primary buccal infection, is a relevant problem in 
children with cancer (4). Candida species, existing in the 
mouth, have high probability to infect the digestive pathways 
and disseminate through the circulation, developing syste-
mic infection that is life threatening for the patient (5). The 
detection and identification of Candida spp. involved in 
oral candidiasis are important for the treatment of patients 
with cancer (6). C. krusei, C. glabrata, C. tropicalis and C. 
dubliniensis species have shown their resistance to certain 
antifungal drugs (6-8). The proposal of this study was the 
identification and frequency of the isolated Candida species 
from buccal lesions in children and adolescents with cancer, 
according to age and sex of patients, clinical presentation, 
type of neoplasic disease and cytostatic therapy received.   
MAtERIALS And MEtHOdS     
-Origin of the sample:
A cross sectional study was carried out  in a  sample (110 
patients) in a given age (0–16 years).These patients were 
admitted to the Pediatric Oncology Unit  at University 
Hospital of Maracaibo (40 patients) and the Oncohema-
tology Unit at  Pediatric Specialities Hospital (70 patients), 
Maracaibo, Venezuela,  from  February  to May, 2003. 
Patients with a diagnosis of malignant neoplasic disease, 
under treatment with cytostatics agents  and with  oral 
candidiasis lesions were chosen for this study (62 patients). 
Patients that received antifungal therapy, ten days prior to 
the study, had either active extensive caries, dental calculus 
or intraoral appliances were excluded.   
This investigation was carried out according to the norms 
proposed in the Declaration of Helsinki. The ethics com-
mittee of each one of the hospitals involved approved the 
development of this study. All the parents or legal guardians 
of the selected children signed a consent report after explai-
ning the purpose of the study.    
-Isolation and identification of Candida species 
The samples were taken by scaling the lesions with a ste-
rile wooden spatula, a direct exam was done to verify the 
microscopic characteristic of  the Candida spp. (presence 
of  pseudomycelia and blastoconidia) and were cultured 
on  CHROMagar Candida  (CHROMagar Candida, Paris, 
France) and  Sabouraud Dextrose Agar with chloramphe-
nicol  for yeast isolation. The cultures were incubated at 
37ºC for 3 to 7 days.
The CHROMagar -Candida medium contains chromogenic 
substances that allow a presumptive diagnosis and identifi-
cation of some species of Candida genus. It was prepared 
according to the manufacturer indications. The macroscopic 
study, after 72 hours, considered: number, consistency and 
color of the colonies. The isolates that developed a green 
color were identified presumably as Candida albicans, the 
blue ones as Candida tropicalis and the pink as Candida 
krusei.    
The colonies  developed on  Agar Sabouraud Dextrose Agar 
were identified  on the basis  of their micromorphology on 
Rice Tween 80(Dalmau Technique) and biochemical tests: 
carbohydrate fermentation by the Wickerham technique 
(glucose, galactose, lactose, maltose, sucrose, trehalose 
(2%), raffinose (4%)) and carbohydrate assimilation by the 
auxanographic technique in plaque (glucose, cellobiose, 
galactose, maltose, saccharose, lactose, sorbose, erythritol, 
trehalose, raffinose, inositol, xylose, melibiose, melezitose, 
rhamnose, mannitol), according to traditional methodology 
(9).    
-Statistical analysis    
Descriptive Statistics were used to present data in absolute 
and percent values, and summarized in tables. The Chi 
square test and the exact test of Fisher the tests were used 
for the statistical analysis. A 95% statistical confidence index 
was established (p<0,05) and the statistical package used 
was SPSS 10.0 (SPSS Inc., Chicago, IL, USA).   
RESuLtS  
The samples studied (62 patients) showed that most of the 
patients were positive to oral candidiasis (43; 69.35%) both 
female (24; 38.70%) and male (19; 30.65%). The group of 
children (23 patients) between 7 and 12 years presented the 
highest number of positive cases (20 patients).The sample 
(8 patients) of the group  between  0 and 2 years showed a 
relatively high number (6 cases) of oral candidiasis.
The distribution of  Candida species isolated from oral 
candidiasis in children and adolescents with cancer, accor-
ding to clinical presentation and type of cancer, are shown 
in Tables 1 and 2. Candida albicans was the most frequent 
species isolated in the malignant neoplasic disease.
dISCuSSIOn
Oral candidiasis represents a problem for children with 
cancer due to the possibility of a systemic infection that 
may be life threatening for the patient. It has been reported 
that the use of  preventive therapy, before the establish-
ment of chemotherapy, may decrease the incidence of oral 
candidiasis (10).    
Most of the patients (69.35%) of the studied sample had 
oral candidiasis as has been previosuly reported (11). The 
highest incidence was observed in children with ages between 
7 and 12 years old. This finding could be due to the mixed 
dentition and the concomitant presence of  the salivary 
pellicle that could favor the adherence of Candida species 
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table 1. Distribution of Candida species isolated from oral candidiasis in children and adolescents with cancer accor-
ding to clinical presentation______________________________________________________________________________
            Clinical Presentation 
       Pseudomembranous            Erythematous                    Total 
 
Candida species.               n°              %                  n°             %                    n°         %                        
 
 
Candida albicans            14             29.78                 6            12.77            20        42.55                     
 
Candida parapsilosis       7               14.89                  -              -                  7        14.89                                                                                       
 
Candida tropicalis           5               10.63                 1             2,13               6        12,76                        
 
Candida krusei                 2                 4.26                  -                -                 2         4.26                                 
  
Candida glabrata             1                 2.13                   -                -                1         2.13                    
 
Candida lusitaniae            -                   -                    1             2.13               1         2.13                                
 
Candida sp                        8                17.02               2            4.26              10        21.28 
                     
Total                                 37              78.71               10           21.29            47         100        
 
P> 0.05 
  The sample was taken in  Maracaibo,  Zulia State, Venezuela. South America     
table 2. Distribution of Candida species isolated from oral candidiasis in children and adolescents with cancer according to type 
of cancer.
Species of Candida
Type of Cancer* C albicans  C parapsilosis   C tropicalis   C krusei   C glabrata  C lusitaniae   C. sp Total
Retinoblastoma              2         -    -                     -             -  -                 -  2
Acute Lymphoid           13                5                   2             1    -                  1               8         30
Leukemia
Rabdomyosarcoma          1     1                      -                     -          -                 -                -           2
Meduloblastoma              1              -      1                     1              -                -                  -       3
Acute non Lymphoid       -   -                        1                     -           1               -                 -          2  
Leukemia
Grade I Astrocytoma        1     -  1                     -            -               -  -          2
  Total     20               7             6    2                  1       1     10           47
p 0
*It was identified  1 only case in several types of cancer, i.e. Epidermoma  Anaplastic and  Ewing’s Sarcoma (C. albicans); Non-Hod-
king’s Lymphoma(C. parapsilosis); Neuroblastoma (C.tropicalis); Osteosarcoma and Ovary Tumor (Candida sp).
The sample was taken in Maracaibo, Zulia State, Venezuela. South America.
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to the epithelial surface (12). Also the physical conditions 
of these children may contribute to an unsuitable buccal 
hygiene. The prevalence of positive cases in female popula-
tion as previously observed (13,14), did not represent any 
significant difference.
The pseudomembranous clinical presentation was mainly 
observed (78.71%) in the positive cases while the erythe-
matous ones were lower (21.29%). The relationship bet-
ween clinical presentations and the isolated Candida spp is 
shown in Table 1. C. albicans was predominantly isolated 
(42.55%), as was observed previously (6, 15, 16), followed 
by C. parapsilosis (14.89%), C. tropicalis (12.76%), C. kru-
sei (4.26%), C. glabrata and C. lusitaniae (2.13%). These 
findings have been previuosly reported (6,17,18) . The high 
frequency of these species may be related to the patients’ 
immunosuppression status and the empirical treatment with 
antibiotic and wide spectrum antimycotics that may cause 
mutation phenomenon (19, 20). 
This finding may explain the reason why some isolated 
Candida species (21.28%) were not identified by the used 
methodology. It is important to note that two different spe-
cies were identified in four cases of oral candidiasis, i.e., C. 
albicans and C. tropicalis (2 cases); C. albicans with C. krusei 
(1 case) and C. tropicalis and C. parapsilosis (1 case).
After chemotherapy, candidiasis pseudomembranous was 
the most frequent clinical presentation in oral candidiasis in 
children and adolescents with cancer, as has been previously 
observed (21-23). The clinical presentations were observed 
mainly in the tongue (72.70%) followed by the inside cheeks 
(12.70%), soft palate (10.90%) and lips (3.60%) as was ob-
served previously (24) but differ in the preferential location, 
hard palate, found in the buccal cavity (25). It is important 
to note that the positive cases (90.70%) were presented as 
non painful lesions.
The distribution of Candida species according to type of 
cancer (Table 2), showed that the patients that suffered 
acute lymphoid leukemia presented the highest number of 
positive cases , in accordance with some reports (26, 27) but 
differed from the predominant oral candidiasis in patients 
with acute myeloid leukemia and sarcoma (4, 11). The in-
cidence of oral candidiasis in patients with leukemia may 
be due to the alteration of the mediated-immunity by cells 
in this pathology and the processes that participate in the 
maturation of lymphocyte and plasmatic cells, generating 
serious alterations in the mediated-immunity by antibodies 
(humoral). These conditions favour the susceptibility to 
fungal infections (28). C. albicans was presented as the most 
frequent specie, either in the acute lymphoid leukemia or 
in the rest of the oncological pathologies evaluated in this 
study; similar results have been reported (21).    
The combination of  cytostatic treatments and isolated 
Candida spp. showed not significant statistically eviden-
ces. However, the combination methotrexate-purinethol 
presented the highest number of cases of Candida species. 
This behavior may be due to the oral complications of the 
pediatric patients with malignant neoplasic pathologies and 
the potential immunosuppressive effect of therapies used in 
this disease that has a direct cytotoxic effect on oral mucosa 
(29,30). The epithelial cells of the buccal mucosa are very 
sensitive to chemotherapeutic drugs, they inhibit the cellu-
lar cycle, attacking the tissues with more mitotic activity. 
Nevertheless this cellular inhibition is unspecific, therefore, 
tissues of rapid renovation like the gastrointestinal mucosa 
are equally affected (31).   
There are certain specific toxic drugs that affect the buccal 
mucosa, such as methotrexate, doxorubicin, cyclophos-
phamide and vincristine, which are frequently used in 
oncological therapies protocols for infants patients (19,20). 
The cytotoxic result of these drugs: are epithelial atrophy 
and necrosis, favoring the colonization by fungus, bacteria 
and viruses.     
Oral candidiasis is a frequent complication in pediatric onco-
logy.  C. albicans is the main etiologic agent, however, there is 
an important participation of other Candida species.
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